Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone Follow-Up could replace hospital stays after common surgeries

NCT ID NCT07714343

Disease control Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether sending patients home on the same day of surgery, with follow-up care via phone calls, home visits, and a mobile app, is as safe and less costly than keeping them in the hospital overnight. The trial includes adults in Uganda having low-risk procedures such as hernia repair, thyroid removal, or appendix removal. Half the participants go home with the Recovery@Home program, while the other half stay in the hospital as usual. Researchers track complications within 30 days and compare costs to patients and the hospital.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Recovery@Home model: same-day discharge with nurse phone calls, home visits, mobile-app monitoring, and surgeon teleconsultation
What this could lead to
If successful, this approach could make surgery recovery more convenient and affordable for patients in low-resource settings.
What could go wrong
The trial is relatively small and only includes low-risk procedures, so results may not apply to more complex surgeries or other hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 194 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2027

An estimate. Start dates often move.

Expected to finish

Nov 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * Age 18 years or older. * Undergoing one of the eligible surgical procedures: inguinal/femoral hernia repair; umbilical/epigastric hernia repair; excision of soft tissue tumors; thyroidectomy; or appendectomy; varicocelectomy, hydrocelectomy. * Able to provide informed consent, with consent read aloud and/or fingerprint signature permitted where approved by local ethics authorities. * Available for inpatient interviews, postoperative clinic visit interviews, and postoperative telephone and/or home follow-up during the 30-day postoperative period. Exclusion criteria: * Clinical determination by the surgeon or anesthesia team that same-day discharge is unsafe or inappropriate. * Inability to provide informed consent or lack of an approved surrogate/alternative consent process if required by the IRB. * Any other exclusion required by the final approved protocol or local regulatory authority. * ASA 3 or higher

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Appendectomy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

appendicitis Hernia, Femoral Hernia, Inguinal Hernia, Umbilical Hernia, Ventral hydrocele soft tissue neoplasm Testicular Hydrocele varicocele

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Appendectomy Hernia, femoral Hernia, inguinal Hernia, umbilical Hernia, ventral Testicular hydrocele Thyroidectomy Varicocele

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hope and Healing Center

    Iganga, Uganda

  • Kyabirwa Surgical Center

    Jinja, Uganda, Uganda

  • Lubaga Hospital

    Kampala, Uganda

  • Mengo Hospital

    Kampala, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.